FindTrial
Sign In

A Comprehensive Assessment of Knowledge, Attitude, and Practices on Biomedical Waste Management in Panchakarma Theatre, Including Quantification of Waste and Exploration of Potential Avenues for Value-Added Product Development

Cross-Sectional Survey to assess Knowledge, Attitude, and Practices on Biomedical Waste Management in Panchakarma theatre along with Quantification of Biomedical Waste and exploring the possibilities of development of Value-Added Products. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094435
Enrollment
150
Registered
2025-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Panchakarma technicians, postgraduate scholars, healthcare professionals, and those involved in Panchakarma therapy and waste handling. 2. Willingness to participate and provide informed consent.

Exclusion criteria

Exclusion criteria: ? Those who refuse participation in the study. ? Administrative and non-clinical staff are not involved in waste management.

Design outcomes

Primary

MeasureTime frame
To evaluate the Knowledge, Attitude, and Practices of Panchakarma healthcare professionals regarding BMW management, by developing a questionnaire.Timepoint: at baseline—

Secondary

MeasureTime frame
To quantify the types & amounts of biomedical waste generated in the Panchakarma theatre. To explore the possibilities of converting Panchakarma bio-medical waste into value-added products. Timepoint: at baseline—

Countries

India

Contacts

Public ContactDR PRASANTH DHARMARAJAN

All India Institute of Ayurveda

dr.ananthramsharma@gmail.com9495130595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026